In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML
about
The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth controlThe RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complexPML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma proteinTRIM family proteins: retroviral restriction and antiviral defenceCoactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression.From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemiaA novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteinsStructural insights into the TRIM family of ubiquitin E3 ligasesPML protein isoforms and the RBCC/TRIM motifStructural organization and Zn2+-dependent subdomain interactions involving autoantigenic epitopes in the Ring-B-box-coiled-coil (RBCC) region of Ro52Pondering the puzzle of PML (promyelocytic leukemia) nuclear bodies: can we fit the pieces together using an RNA regulon?TRIM15 is a focal adhesion protein that regulates focal adhesion disassembly.Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease.RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growthNuclear domain 10, the site of DNA virus transcription and replication.Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.Genetic studies of mei-P26 reveal a link between the processes that control germ cell proliferation in both sexes and those that control meiotic exchange in DrosophilaThe promyelocytic leukemia nuclear body: sites of activity?AIRE functions as an E3 ubiquitin ligaseCell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein.PML3 Orchestrates the Nuclear Dynamics and Function of TIP60New insights into the role of PML in tumour suppression.The role of PML in the nervous system.TRIM family proteins: emerging class of RING E3 ligases as regulator of NF-κB pathway.The promyelocytic leukemia protein PML has a pro-apoptotic activity mediated through its RING domain.An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm.Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins.B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies.The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.Demonstration of a RNA-dependent nuclear interaction between the promyelocytic leukaemia protein and glyceraldehyde-3-phosphate dehydrogenaseStructure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.LZF1/SALT TOLERANCE HOMOLOG3, an Arabidopsis B-box protein involved in light-dependent development and gene expression, undergoes COP1-mediated ubiquitination.Molecular cloning and characterization of RBCK2, a splicing variant of a RBCC family protein, RBCK1.Arabidopsis CONSTANS-LIKE3 is a positive regulator of red light signaling and root growth.Visualization of PML nuclear import complexes reveals FG-repeat nucleoporins at cargo retrieval sites.RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
P2860
Q22010929-ACAFB9DB-27F5-43DA-B85B-7036B226C964Q22254714-FBCC810F-03D6-4CD3-B394-D1A8C89D8EE3Q24291551-737BA686-015D-426A-8526-038BAB3893E3Q24324766-83307E94-704B-4DDB-B491-3A71EB9A3731Q24329175-EAFE0BFD-85F8-4AD5-9CBB-CF5FE40AA344Q24522749-96E7C3BD-8B40-4311-AF3A-88714BF7C6EBQ24605527-F0B8C6A8-5C80-420E-B3D6-5978EC852DA5Q24654804-19426DAA-6B1D-491C-A753-B6E5A5821667Q27683218-522ADAFD-DDB6-4B87-BE48-224DE3A15A17Q28204823-A92A3673-01F8-4FA6-B398-F990CB2FB05DQ28257418-8E7BA54E-E384-4D90-B539-261DFFF338DEQ28755220-21A5B600-BACA-4292-B414-2B590D3CF12BQ30586940-5E00EE4B-07D9-4FCC-A88A-9AFB5CE1A321Q33337386-A721F04E-96B2-4523-8CC3-465D889FBC95Q33551142-C2186B64-F140-495F-8FCA-AED6685E6171Q33723609-7D5812F9-B787-4D27-9B33-B6278D428A2DQ34044752-44735E2C-AECC-4F65-80B1-46B668A1F926Q34476075-DC6B2081-510A-4857-9A88-DC810B6B282BQ34545869-362650CA-9AF8-4325-A397-1A7754C2EDBCQ34610042-7EE041F3-7AF9-42F4-9AAD-50A01A8B608BQ34746892-9EF0164F-3119-4722-94E0-814E5206B85CQ36399016-B06AF342-CF87-4FBE-B4B6-8275E7754275Q36600855-705E224D-9A21-44FD-B26A-740CD487D320Q37136820-87E8C998-1A18-4A51-A8EC-E463606E1689Q37173760-8D7E7E00-0DDD-4A3B-81BE-4749959D5DDDQ37821367-DAD02900-D4A1-4B05-BEDE-3311191B864CQ38260549-E7B7F203-D927-47D7-8D75-16411EDB2205Q38341153-231A4790-D7BA-4013-BCC9-AD698E767E35Q39577454-FCB1B034-CDC2-4435-90A6-0200F20CCDB3Q39578325-C1A0EBFA-87C7-43D9-A9F3-2416003FAD49Q39845286-F578B243-2141-402C-A620-44B878B5EA96Q40887272-F2F1855F-7690-460C-A197-051BC92C4D82Q40998374-BCEADD97-89BF-4FC1-BA7D-5F64881B8571Q41840026-FC1B2F44-EDFB-4733-8C0F-018234117C7BQ44821722-E4C5FCE9-8CB0-4DC5-9FAB-EFDE36EFACAAQ48019335-DAFAD066-F498-427F-9C7A-B9C8554B2FCFQ50745674-3965EFC3-2EDA-459B-B080-E9B97F490777Q51062331-57D851C4-00EE-4D65-86CB-209D8CDCC531Q55077521-DA5294F3-C3E3-4350-847A-4D7740D4A97E
P2860
In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
In vivo and in vitro character ...... leukemia protooncoprotein PML
@ast
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en-gb
In vivo and in vitro character ...... leukemia protooncoprotein PML
@nl
type
label
In vivo and in vitro character ...... leukemia protooncoprotein PML
@ast
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en-gb
In vivo and in vitro character ...... leukemia protooncoprotein PML
@nl
prefLabel
In vivo and in vitro character ...... leukemia protooncoprotein PML
@ast
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en-gb
In vivo and in vitro character ...... leukemia protooncoprotein PML
@nl
P2093
P2860
P356
P1476
In vivo and in vitro character ...... leukemia protooncoprotein PML
@en
P2093
K L Borden
N J O'Reilly
P S Freemont
S R Martin
P2860
P304
P356
10.1073/PNAS.93.4.1601
P407
P577
1996-02-20T00:00:00Z